News about Engineering

Sapient Launches Tumor Protein Mapping Platform to Characterise Functional Biology Across Critical Dimensions in Human Tumors

Sapient Launches Tumor Protein Mapping Platform to Characterise Functional Biology Across Critical Dimensions in Human Tumors

Sapient’s Protein Mapping Platforms include SurfaceSeek to identify druggable tumor cell surface proteins, SignalingSeek to measure signaling pathway activation, and ImmuneSeek and ResistanceSeek to map immune and resistance biology–directly in fresh-frozen and FFPE human tumor.

Engineering | 30/04/2026 | By News Bureau

Nova Polymers Inc. Launches Pure Exterior Substrate for ADA Signage

Nova Polymers Inc. Launches Pure Exterior Substrate for ADA Signage

Nova Polymers Inc. launches Novacryl EX, an exterior-grade photopolymer substrate engineered for durable, ADA-compliant signage, offering high moisture and humidity resistance for long-lasting performance and adherence to regulatory standards.

Engineering | 27/04/2026 | By News Bureau

UK MHRA Approves Single-Dose 7.2mg Wegovy Injection for Obesity Treatment

UK MHRA Approves Single-Dose 7.2mg Wegovy Injection for Obesity Treatment

The UK Medicines and Healthcare products Regulatory Agency has approved a single-dose 7.2mg Wegovy pen, simplifying weekly treatment for adults with obesity and a BMI of 30 or higher.

Engineering | 15/04/2026 | By News Bureau

Caris Launches World's First ChromoSeq for Myeloid Malignancies

Caris Launches World's First ChromoSeq for Myeloid Malignancies

Caris Life Sciences launches ChromoSeq, the world’s first whole genome and transcriptome assay for myeloid malignancies, offering deeper insights and faster diagnosis.

Engineering | 06/04/2026 | By News Bureau 115

MHRA and FDA Partner to Fast-Track Innovative Medical Devices for Patients

MHRA and FDA Partner to Fast-Track Innovative Medical Devices for Patients

The Medicines and Healthcare products Regulatory Agency (MHRA) is strengthening its collaboration with the US Food and Drug Administration (FDA) to accelerate patient access to safe and innovative medical technologies in both the United Kingdom and the United States.

Engineering | 06/04/2026 | By Darshana 100

Roche Strengthens Diagnostics Portfolio with New Multiplex PCR Assay

Roche Strengthens Diagnostics Portfolio with New Multiplex PCR Assay

Roche has announced the availability of its cobas MPX-E assay, a qualitative in-vitro diagnostic test designed to simultaneously detect and differentiate HIV-1, HIV-2, Hepatitis B, C, and E viruses.

Engineering | 31/03/2026 | By Darshana 129

CDSCO Cracks Down on Unlicensed IVF Medical Devices

CDSCO Cracks Down on Unlicensed IVF Medical Devices

The Central Drugs Standard Control Organisation (CDSCO) has directed its zonal and sub-zonal offices, along with State Licensing Authorities (SLAs), to maintain strict vigilance against the sale of unlicensed medical devices used in In Vitro Fertilisation (IVF) and Assisted Reproductive Technology (ART) procedures.

Engineering | 30/03/2026 | By Darshana 115

Neuberg Diagnostics Launches Blood-Based Test for Early Alzheimer's Detection

Neuberg Diagnostics Launches Blood-Based Test for Early Alzheimer's Detection

Neuberg Diagnostics, Chennai, has introduced Mispa i60, a simple blood-based test designed to detect early signs of Alzheimer’s disease, offering a non-invasive and cost-effective screening solution.

Engineering | 26/03/2026 | By Darshana 100

Merck & Co. Nears USD 6 Billion Deal to Acquire Terns Pharmaceuticals, Strengthening Oncology Pipeline

Merck & Co. Nears USD 6 Billion Deal to Acquire Terns Pharmaceuticals, Strengthening Oncology Pipeline

Merck & Co. is reportedly nearing a USD 6 billion acquisition of Terns Pharmaceuticals, as part of its strategy to strengthen its oncology portfolio and prepare for future growth.

Engineering | 25/03/2026 | By Darshana 118

Everest Medicines Acquires Greater China Rights to Cardamyst Nasal Spray in USD 50 Million Deal

Everest Medicines Acquires Greater China Rights to Cardamyst Nasal Spray in USD 50 Million Deal

Everest Medicines has entered into an asset purchase agreement with Corxel Pharmaceuticals Hong Kong Limited to acquire exclusive rights to develop, manufacture, and commercialize Cardamyst (etripamil) nasal spray across Greater China, including mainland China, Hong Kong, Macao, and Taiwan.

Engineering | 24/03/2026 | By Darshana

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members